SM

Sai Mamidi Praveen

Director Director DIN 06618941
DIN 06618941 First appointment Jun 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 3 historical roles
Total affiliations 3 Since Jun 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Sai Mamidi Praveen

Data last updated:

Sai Mamidi Praveen was a Director at S D Life Sciences India Private Limited (2013–2018), Director at G.S.Lifesciences Private Limited (from 2013) and Director at Swan Drugs India Private Limited (from 2013). The companies operate in Pharma.

DIN 06618941
Primary Designation Director
Industry Pharma
First Appointment 01 Jun 2013
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jul 20132013₹10.86 Cr (FY 2024)Active
G.S.Lifesciences Private Limited U24232TG2007PTC055916
Director01 Jun 20132007Strike Off
Swan Drugs India Private Limited U24233TG2013PTC090723
Director26 Oct 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
G.S.Lifesciences Private Limited
Swan Drugs India Private Limited
S D Life Sciences India Private Limited
Premium access

Shareholding and investment profile for Sai Mamidi Praveen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Mamidi Praveen

Sai Mamidi Praveen was first appointed on 01 Jun 2013 as Director at G.S.Lifesciences Private Limited.

Sai Mamidi Praveen held 3 earlier board appointments: S D Life Sciences India Private Limited (Director, 09 Jul 2013 to 12 Sep 2018); G.S.Lifesciences Private Limited (Director, from 01 Jun 2013); Swan Drugs India Private Limited (Director, from 26 Oct 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available